The plasma lipopolysaccharide level is associated with contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction

Abstract Background Lipopolysaccharide (LPS) plays an important role in cardiovascular and renal diseases. However, the relationship between LPS and contrast-induced acute kidney injury (CI-AKI) remains unclear. This study aimed to investigate the role of LPS in patients with ST-segment elevation my...

Full description

Saved in:
Bibliographic Details
Main Authors: Haiqiang Shen, Qinghuan Yang, Xiaofu Zhang, Shan Qin, Yong Li, Jinqi Liu
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-025-04959-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849388140394971136
author Haiqiang Shen
Qinghuan Yang
Xiaofu Zhang
Shan Qin
Yong Li
Jinqi Liu
author_facet Haiqiang Shen
Qinghuan Yang
Xiaofu Zhang
Shan Qin
Yong Li
Jinqi Liu
author_sort Haiqiang Shen
collection DOAJ
description Abstract Background Lipopolysaccharide (LPS) plays an important role in cardiovascular and renal diseases. However, the relationship between LPS and contrast-induced acute kidney injury (CI-AKI) remains unclear. This study aimed to investigate the role of LPS in patients with ST-segment elevation myocardial infarction (STEMI) and its relationship with CI-AKI following percutaneous coronary intervention (PCI). Methods This single-centre retrospective observational study included 710 patients diagnosed with STEMI. CI-AKI was defined as an increase in SCr of at least 50% or 0.3 mg/dL within 48–72 h after contrast exposure. Regression analysis was used to identify potential risk factors. Restricted cubic splines (RCSs) were used to explore the dose‒response relationship between LPS levels and CI-AKI. The models were evaluated using receiver operating characteristic (ROC) curves, the net reclassification index (NRI), and the integrated discrimination improvement (IDI) index. Results The incidence of CI-AKI during hospitalization was 12.5%. After adjusting for potential confounding factors, the results revealed that LPS (OR = 0.650, 95% CI: 0.466–0.906) was an independent risk factor that affected the occurrence of CI-AKI. The RCS results revealed a linear dose‒response relationship between LPS and CI-AKI. After integration of LPS, the model demonstrated a significantly improved ability to predict CI-AKI (IDI 0.095, P < 0.001; NRI 0.720, P < 0.001). Conclusion Elevated LPS is an independent risk factor for the development of CI-AKI after PCI in patients with STEMI. The integration of LPS detection significantly improved the risk model for CI-AKI.
format Article
id doaj-art-519d609ea1e743cf9db22d8d283d1e37
institution Kabale University
issn 1471-2261
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj-art-519d609ea1e743cf9db22d8d283d1e372025-08-20T03:42:23ZengBMCBMC Cardiovascular Disorders1471-22612025-07-012511910.1186/s12872-025-04959-3The plasma lipopolysaccharide level is associated with contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarctionHaiqiang Shen0Qinghuan Yang1Xiaofu Zhang2Shan Qin3Yong Li4Jinqi Liu5Department of Gastroenterology, the First People’s Hospital of Yuhang DistrictDepartment of Cardiology, the First People’s Hospital of Yuhang DistrictDepartment of Cardiology, the First People’s Hospital of Yuhang DistrictDepartment of Cardiology, the First People’s Hospital of Yuhang DistrictDepartment of Cardiology, the First People’s Hospital of Yuhang DistrictDepartment of Cardiology, Huai’an Second People’s HospitalAbstract Background Lipopolysaccharide (LPS) plays an important role in cardiovascular and renal diseases. However, the relationship between LPS and contrast-induced acute kidney injury (CI-AKI) remains unclear. This study aimed to investigate the role of LPS in patients with ST-segment elevation myocardial infarction (STEMI) and its relationship with CI-AKI following percutaneous coronary intervention (PCI). Methods This single-centre retrospective observational study included 710 patients diagnosed with STEMI. CI-AKI was defined as an increase in SCr of at least 50% or 0.3 mg/dL within 48–72 h after contrast exposure. Regression analysis was used to identify potential risk factors. Restricted cubic splines (RCSs) were used to explore the dose‒response relationship between LPS levels and CI-AKI. The models were evaluated using receiver operating characteristic (ROC) curves, the net reclassification index (NRI), and the integrated discrimination improvement (IDI) index. Results The incidence of CI-AKI during hospitalization was 12.5%. After adjusting for potential confounding factors, the results revealed that LPS (OR = 0.650, 95% CI: 0.466–0.906) was an independent risk factor that affected the occurrence of CI-AKI. The RCS results revealed a linear dose‒response relationship between LPS and CI-AKI. After integration of LPS, the model demonstrated a significantly improved ability to predict CI-AKI (IDI 0.095, P < 0.001; NRI 0.720, P < 0.001). Conclusion Elevated LPS is an independent risk factor for the development of CI-AKI after PCI in patients with STEMI. The integration of LPS detection significantly improved the risk model for CI-AKI.https://doi.org/10.1186/s12872-025-04959-3Contrast-induced acute kidney injuryLipopolysaccharideSTEMIAcute kidney injuryPercutaneous coronary intervention
spellingShingle Haiqiang Shen
Qinghuan Yang
Xiaofu Zhang
Shan Qin
Yong Li
Jinqi Liu
The plasma lipopolysaccharide level is associated with contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction
BMC Cardiovascular Disorders
Contrast-induced acute kidney injury
Lipopolysaccharide
STEMI
Acute kidney injury
Percutaneous coronary intervention
title The plasma lipopolysaccharide level is associated with contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction
title_full The plasma lipopolysaccharide level is associated with contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction
title_fullStr The plasma lipopolysaccharide level is associated with contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction
title_full_unstemmed The plasma lipopolysaccharide level is associated with contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction
title_short The plasma lipopolysaccharide level is associated with contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction
title_sort plasma lipopolysaccharide level is associated with contrast induced acute kidney injury in patients with st segment elevation myocardial infarction
topic Contrast-induced acute kidney injury
Lipopolysaccharide
STEMI
Acute kidney injury
Percutaneous coronary intervention
url https://doi.org/10.1186/s12872-025-04959-3
work_keys_str_mv AT haiqiangshen theplasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction
AT qinghuanyang theplasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction
AT xiaofuzhang theplasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction
AT shanqin theplasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction
AT yongli theplasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction
AT jinqiliu theplasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction
AT haiqiangshen plasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction
AT qinghuanyang plasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction
AT xiaofuzhang plasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction
AT shanqin plasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction
AT yongli plasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction
AT jinqiliu plasmalipopolysaccharidelevelisassociatedwithcontrastinducedacutekidneyinjuryinpatientswithstsegmentelevationmyocardialinfarction